HT Law is an accomplished scientist with extensive experience in cell line development, protein engineering, and synthetic biology, currently serving as a Scientist in Cell Line Development GMP at STEMCELL Technologies since May 2022. Previous roles include BIS 1 at adMare BioInnovations and Protein Engineering Scientist at bioLytical, where expertise in scaling recombinant antigen production was developed. At InMed Pharmaceuticals, HT Law managed R&D for cannabinoid biosynthesis, enhancing production for clinical applications. Additional post-doctoral fellowships at BC Children's Hospital Research Institute and McMaster University focused on microbiological and immunological studies, resulting in publications in prominent journals. HT Law holds a PhD in Biological Sciences and a BSc in Biochemistry and Molecular Biology from Simon Fraser University. Proficiencies include advanced laboratory techniques and data analysis with Python and R.
This person is not in the org chart
This person is not in any teams
This person is not in any offices